{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:38:00Z","timestamp":1763746680623},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1007\/s11938-007-0068-1","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T23:33:16Z","timestamp":1205451196000},"page":"157-168","source":"Crossref","is-referenced-by-count":5,"title":["Current treatments in functional dyspepsia"],"prefix":"10.1007","volume":"10","author":[{"given":"Meredythe A.","family":"McNally","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Talley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,15]]},"reference":[{"key":"68_CR1","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2005.00225.x","volume":"100","author":"N.J. Talley","year":"2005","unstructured":"Talley NJ, Vakil N: Guidelines for the management of dyspepsia. Am J Gastroenterol 2005, 100:2324\u20132337.","journal-title":"Am J Gastroenterol"},{"key":"68_CR2","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/0016-5085(94)90228-3","volume":"107","author":"N.J. Talley","year":"1994","unstructured":"Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd: Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology 1994, 107:1040\u20131049.","journal-title":"Gastroenterology"},{"key":"68_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/003655299750025255","volume":"231","author":"A. Haycox","year":"1999","unstructured":"Haycox A, Einarson T, Eggleston A: The health economic impact of upper gastrointestinal symptoms in the general population: results from the Domestic\/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999, 231:38\u201347.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"68_CR4","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1056\/NEJM199811053391907","volume":"339","author":"R.S. Fisher","year":"1998","unstructured":"Fisher RS, Parkman HP: Management of nonulcer dyspepsia. N Engl J Med 1998, 339:1376\u20131381.","journal-title":"N Engl J Med"},{"key":"68_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2036.2003.01805.x","volume":"19","author":"G.D. Eslick","year":"2004","unstructured":"Eslick GD, Howell SC, Hammer J, Talley NJ: Empirically derived symptom sub-groups correspond poorly with diagnostic criteria for functional dyspepsia and irritable bowel syndrome. A factor and cluster analysis of a patient sample. Aliment Pharmacol Ther 2004, 19:133\u2013140.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR6","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","volume":"130","author":"J. Tack","year":"2006","unstructured":"Tack J, Talley NJ, Camilleri M, et al.: Functional gastroduodenal disorders. Gastroenterology 2006, 130:1466\u20131479.","journal-title":"Gastroenterology"},{"key":"68_CR7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1055\/s-2006-944661","volume":"38","author":"L.A. Kerkhoven van","year":"2006","unstructured":"van Kerkhoven LA, van Rossum LG, van Oijen MG, et al.: Upper gastrointestinal endoscopy does not reassure patients with functional dyspepsia. Endoscopy 2006, 38:879\u2013885.","journal-title":"Endoscopy"},{"key":"68_CR8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.48.3.347","volume":"48","author":"C. Feinle","year":"2001","unstructured":"Feinle C, Meier O, Otto B, et al.: Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001, 48:347\u2013355.","journal-title":"Gut"},{"key":"68_CR9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/gast.1997.v113.pm9247458","volume":"113","author":"A.M. Accarino","year":"1997","unstructured":"Accarino AM, Azpiroz F, Malagelada JR: Attention and distraction: effects on gut perception. Gastroenterology 1997, 113:415\u2013422.","journal-title":"Gastroenterology"},{"key":"68_CR10","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/gut.52.10.1414","volume":"52","author":"C. Feinle-Bisset","year":"2003","unstructured":"Feinle-Bisset C, Meier B, Fried M, Beglinger C: Role of cognitive factors in symptom induction following high and low fat meals in patients with functional dyspepsia. Gut 2003, 52:1414\u20131418.","journal-title":"Gut"},{"key":"68_CR11","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1111\/j.1572-0241.2003.08724.x","volume":"98","author":"P. Moayyedi","year":"2003","unstructured":"Moayyedi P, Deeks J, Talley NJ, et al.: An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003, 98:2621\u20132626.","journal-title":"Am J Gastroenterol"},{"key":"68_CR12","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1023\/B:DDAS.0000007856.71462.6c","volume":"48","author":"G. Sarnelli","year":"2003","unstructured":"Sarnelli G, Cuomo R, Janssens J, Tack J: Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without Helicobacter pylori. Dig Dis Sci 2003, 48:2229\u20132236.","journal-title":"Dig Dis Sci"},{"key":"68_CR13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0016-5085(98)70542-6","volume":"114","author":"N.J. Talley","year":"1998","unstructured":"Talley NJ, Silverstein MD, Agreus L, et al.: AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998, 114:582\u2013595.","journal-title":"Gastroenterology"},{"key":"68_CR14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","volume":"127","author":"P. Moayyedi","year":"2004","unstructured":"Moayyedi P, Delaney BC, Vakil N, et al.: The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004, 127:1329\u20131337.","journal-title":"Gastroenterology"},{"key":"68_CR15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","volume":"12","author":"N.J. Talley","year":"1998","unstructured":"Talley NJ, Meineche-Schmidt V, Pare P, et al.: Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998, 12:1055\u20131065.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR16","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1046\/j.1365-2036.2001.01044.x","volume":"15","author":"H.A. Redstone","year":"2001","unstructured":"Redstone HA, Barrowman N, Veldhuyzen Van Zanten SJ: H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials. Aliment Pharmacol Ther 2001, 15:1291\u20131299.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1365-2036.2003.01575.x","volume":"17","author":"P. Moayyedi","year":"2003","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Systematic review: antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 2003, 17:1215\u20131227.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR18","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-2036.2006.03102.x","volume":"24","author":"A.B. Grudell","year":"2006","unstructured":"Grudell AB, Camilleri M, Burton DD, Stephens DA: Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study. Aliment Pharmacol Ther 2006, 24:1037\u20131043.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1572-0241.2003.07389.x","volume":"98","author":"G. Sarnelli","year":"2003","unstructured":"Sarnelli G, Caenepeel P, Geypens B, et al.: Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003, 98:783\u2013788.","journal-title":"Am J Gastroenterol"},{"key":"68_CR20","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1023\/A:1018803129779","volume":"43","author":"A.O. Quartero","year":"1998","unstructured":"Quartero AO, de Wit NJ, Lodder AC, et al.: Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998, 43:2028\u20132033.","journal-title":"Dig Dis Sci"},{"key":"68_CR21","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/gut.2005.105601","volume":"55","author":"N.J. Talley","year":"2006","unstructured":"Talley NJ, Locke GR 3rd, Tack J: Does delayed gastric emptying really cause symptoms in functional dyspepsia? We still doubt it! Gut 2006, 55:1674. Author reply 1674.","journal-title":"Gut"},{"key":"68_CR22","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1053\/j.gastro.2004.09.006","volume":"127","author":"S. Delgado-Aros","year":"2004","unstructured":"Delgado-Aros S, Camilleri M, Cremonini F, et al.: Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004, 127:1685\u20131694.","journal-title":"Gastroenterology"},{"key":"68_CR23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.1995.tb00359.x","volume":"9","author":"N.J. Talley","year":"1995","unstructured":"Talley NJ: Review article: functional dyspepsia\u2014should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995, 9:107\u2013115.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR24","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJMoa052639","volume":"354","author":"G. Holtmann","year":"2006","unstructured":"Holtmann G, Talley NJ, Liebregts T, et al.: A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006, 354:832\u2013840.","journal-title":"N Engl J Med"},{"key":"68_CR25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0002-9270(00)02314-5","volume":"96","author":"S.J. Veldhuyzen van Zanten","year":"2001","unstructured":"Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ: Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001, 96:689\u2013696.","journal-title":"Am J Gastroenterol"},{"key":"68_CR26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1542-3565(04)00059-X","volume":"2","author":"F. Mearin","year":"2004","unstructured":"Mearin F, Rodrigo L, Perez-Mota A, et al.: Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. Clin Gastroenterol Hepatol 2004, 2:301\u2013308.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"68_CR27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-2982.2005.00715.x","volume":"17","author":"L. Degen","year":"2005","unstructured":"Degen L, Petrig C, Studer D, et al.: Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil 2005, 17:821\u2013826.","journal-title":"Neurogastroenterol Motil"},{"key":"68_CR28","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2036.2003.01775.x","volume":"18","author":"J. Tack","year":"2003","unstructured":"Tack J, Vos R, Janssens J, et al.: Influence of tegaserod on proximal gastric tone and on the perception of gastric distension. Aliment Pharmacol Ther 2003, 18:1031\u20131037.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR29","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1365-2036.2006.02940.x","volume":"23","author":"J. Tack","year":"2006","unstructured":"Tack J, Middleton SJ, Horne MC, et al.: Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2006, 23:1655\u20131665.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1542-3565(04)00391-X","volume":"2","author":"M. Camilleri","year":"2004","unstructured":"Camilleri M, McKinzie S, Fox J, et al.: Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2004, 2:895\u2013904.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"68_CR31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1365-2036.2002.01236.x","volume":"16","author":"B.I. Hallerback","year":"2002","unstructured":"Hallerback BI, Bommelaer G, Bredberg E, et al.: Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment Pharmacol Ther 2002, 16:959\u2013967.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl2","key":"68_CR32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2036.2005.02473.x","volume":"21","author":"M. Otaka","year":"2005","unstructured":"Otaka M, Jin M, Odashima M, et al.: New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment Pharmacol Ther 2005, 21(Suppl 2):42\u201346.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR33","first-page":"735","volume":"102","author":"D.N. Amarapurkar","year":"2004","unstructured":"Amarapurkar DN, Rane P: Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia. J Indian Med Assoc 2004, 102:735\u2013737, 760.","journal-title":"J Indian Med Assoc"},{"key":"68_CR34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/gut.2003.035279","volume":"54","author":"J. Arts","year":"2005","unstructured":"Arts J, Caenepeel P, Verbeke K, Tack J: Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut 2005, 54:455\u2013460.","journal-title":"Gut"},{"key":"68_CR35","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1365-2036.2000.00868.x","volume":"14","author":"N.J. Talley","year":"2000","unstructured":"Talley NJ, Verlinden M, Snape W, et al.: Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000, 14:1653\u20131661.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2982.2005.00675.x","volume":"17","author":"J.J. Galligan","year":"2005","unstructured":"Galligan JJ, Vanner S: Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol Motil 2005, 17:643\u2013653.","journal-title":"Neurogastroenterol Motil"},{"key":"68_CR37","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","volume":"115","author":"J. Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, et al.: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115:1346\u20131352.","journal-title":"Gastroenterology"},{"key":"68_CR38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(99)70179-4","volume":"116","author":"M. Thumshirn","year":"1999","unstructured":"Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR: Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 1999, 116:573\u2013585.","journal-title":"Gastroenterology"},{"key":"68_CR39","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1053\/gast.2002.33663","volume":"122","author":"J. Tack","year":"2002","unstructured":"Tack J, Demedts I, Dehondt G, et al.: Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002, 122:1738\u20131747.","journal-title":"Gastroenterology"},{"key":"68_CR40","first-page":"G373","volume":"276","author":"B. Coulie","year":"1999","unstructured":"Coulie B, Tack J, Sifrim D, et al.: Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am J Physiol 1999, 276:G373\u2013G377.","journal-title":"Am J Physiol"},{"key":"68_CR41","doi-asserted-by":"crossref","first-page":"G988","DOI":"10.1152\/ajpgi.00419.2003","volume":"287","author":"G. Sarnelli","year":"2004","unstructured":"Sarnelli G, Sifrim D, Janssens J, Tack J: Influence of sildenafil on gastric sensorimotor function in humans. Am J Physiol Gastrointest Liver Physiol 2004, 287:G988\u2013G992.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"68_CR42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2003.01469.x","volume":"17","author":"J. Tack","year":"2003","unstructured":"Tack J, Broekaert D, Coulie B, et al.: Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther 2003, 17:603\u2013608.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","volume":"93","author":"H. Mertz","year":"1998","unstructured":"Mertz H, Fass R, Kodner A, et al.: Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998, 93:160\u2013165.","journal-title":"Am J Gastroenterol"},{"key":"68_CR44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2001.00941.x","volume":"15","author":"N.J. Talley","year":"2001","unstructured":"Talley NJ, Van Zanten SV, Saez LR, et al.: A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 2001, 15:525\u2013537.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2036.2002.01144.x","volume":"16","author":"B. Kuo","year":"2002","unstructured":"Kuo B, Camilleri M, Burton D, et al.: Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans. Aliment Pharmacol Ther 2002, 16:225\u2013233.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR46","first-page":"G591","volume":"271","author":"C. Feinle","year":"1996","unstructured":"Feinle C, Read NW: Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility. Am J Physiol 1996, 271:G591\u2013G597.","journal-title":"Am J Physiol"},{"key":"68_CR47","doi-asserted-by":"crossref","first-page":"G1468","DOI":"10.1152\/ajpgi.2001.281.6.G1468","volume":"281","author":"B.E. Viramontes","year":"2001","unstructured":"Viramontes BE, Malcolm A, Camilleri M, et al.: Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol Gastrointest Liver Physiol 2001, 281:G1468\u2013G1476.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"68_CR48","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.gastro.2004.07.005","volume":"127","author":"J. Tack","year":"2004","unstructured":"Tack J, Caenepeel P, Corsetti M, Janssens J: Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 2004, 127:1058\u20131066.","journal-title":"Gastroenterology"},{"key":"68_CR49","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2036.2005.02648.x","volume":"22","author":"M. Duncan","year":"2005","unstructured":"Duncan M, Davison JS, Sharkey KA: Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther 2005, 22:667\u2013683.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR50","doi-asserted-by":"crossref","first-page":"R1217","DOI":"10.1152\/ajpregu.2000.278.5.R1217","volume":"278","author":"C. Feinle","year":"2000","unstructured":"Feinle C, Grundy D, Otto B, Fried M: Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans. Am J Physiol Regul Integr Comp Physiol 2000, 278:R1217\u2013R1223.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"68_CR51","doi-asserted-by":"crossref","first-page":"G787","DOI":"10.1152\/ajpgi.2001.280.5.G787","volume":"280","author":"A.J. Kirkup","year":"2001","unstructured":"Kirkup AJ, Brunsden AM, Grundy D: Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents. Am J Physiol Gastrointest Liver Physiol 2001, 280:G787\u2013G794.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"68_CR52","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMoa010564","volume":"345","author":"A. Taguchi","year":"2001","unstructured":"Taguchi A, Sharma N, Saleem RM, et al.: Selective postoperative inhibition of gastrointestinal opioid receptors. N Engl J Med 2001, 345:935\u2013940.","journal-title":"N Engl J Med"},{"key":"68_CR53","doi-asserted-by":"crossref","unstructured":"Tan EK, Cornish J, Darzi AW, Tekkis PP: Meta-analysis: alvimopan vs. placebo in the treatment of post-operative ileus. Aliment Pharmacol Ther 2006 [Epub ahead of print].","DOI":"10.1111\/j.1365-2036.2006.03150.x"},{"key":"68_CR54","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1365-2036.1996.109280000.x","volume":"10","author":"B. Coffin","year":"1996","unstructured":"Coffin B, Bouhassira D, Chollet R, et al.: Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans. Aliment Pharmacol Ther 1996, 10:919\u2013925.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR55","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.41.5.664","volume":"41","author":"N.W. Read","year":"1997","unstructured":"Read NW, Abitbol JL, Bardhan KD, et al.: Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997, 41:664\u2013668.","journal-title":"Gut"},{"key":"68_CR56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2036.2003.01670.x","volume":"18","author":"S. Delgado-Aros","year":"2003","unstructured":"Delgado-Aros S, Chial HJ, Cremonini F, et al.: Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health. Aliment Pharmacol Ther 2003, 18:507\u2013514.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR57","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.1365-2036.2002.01280.x","volume":"16","author":"M. Bortolotti","year":"2002","unstructured":"Bortolotti M, Coccia G, Grossi G, Miglioli M: The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther 2002, 16:1075\u20131082.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR58","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2982.2003.00420.x","volume":"15","author":"J. Fioramonti","year":"2003","unstructured":"Fioramonti J, Gaultier E, Toulouse M, et al.: Intestinal anti-nociceptive behaviour of NK3 receptor antagonism in conscious rats: evidence to support a peripheral mechanism of action. Neurogastroenterol Motil 2003, 15:363\u2013369.","journal-title":"Neurogastroenterol Motil"},{"key":"68_CR59","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1046\/j.1365-2036.2002.01358.x","volume":"16","author":"S.D. Kuiken","year":"2002","unstructured":"Kuiken SD, Lei A, Tytgat GN, et al.: Effect of the low-affinity, noncompetitive N-methyl-d-aspartate receptor antagonist dextromethorphan on visceral perception in healthy volunteers. Aliment Pharmacol Ther 2002, 16:1955\u20131962.","journal-title":"Aliment Pharmacol Ther"},{"key":"68_CR60","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2036.2004.02275.x","volume":"20","author":"J. Melzer","year":"2004","unstructured":"Melzer J, Rosch W, Reichling J, et al.: Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther 2004, 20:1279\u20131287.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-007-0068-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0068-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:36Z","timestamp":1559422596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-007-0068-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["68"],"URL":"https:\/\/doi.org\/10.1007\/s11938-007-0068-1","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}